- Nexletol is Esperion Therapeutics’ drug, the first oral non-statin approved to treat high cholesterol in nearly 20 years.
- Palforzia is Aimmune Therapeutics’ drug, designed to treat peanut allergies by exposing patients to small amounts of peanut powder.
- Tazverik is Epizyme’s drug, the first treatment that specifically targets epithelioid sarcoma, a rare form of soft tissue cancer.
- Micra AV is the world’s smallest pacemaker with atrioventricular synchrony, made by Medtronic.
- Tepezza is Horizon Therapeutics’ drug, the first designed to treat thyroid eye disease.
More articles on pharmacy:
Walgreens told consultants to erase mention of pharmacists complaints, review finds
Pharmacies need to put value over volume, Cleveland Clinic’s chief pharmacy officer says
Hormone-blocking drug is 8 times more expensive when used for kids, report finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
